Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%
ERICKSON AIR EAC
5.10%
ASSURED GUAR AGO
4.98%
Analyst Moves: CYH, SCHW

Print Share

Feb 11, 2013 (MarketNewsVideo.com via COMTEX) -- Community Health Systems (CYH) was downgraded by BMO (BMO) from market perform to underperform with a price target of $35 due to downside risk in the near term.

Shares are lower by about 1.4 percent.

Charles Schwab (SCHW) was downgraded by Citigroup (C) from neutral to sell with a price target of $14, as the company lacks 2013 operating leverage.

Shares are lower by about eight tenths of a percent.

The preceding is a transcript of the MarketNewsVideo.com video published at: http://www.marketnewsvideo.com/?id=201302Downgrades021113&mv=1.

http://www.marketnewsvideo.com/

Copyright 2013 MarketNewsVideo.com

**********************************************************************

As of Thursday, 02-07-2013 23:59, the latest Comtex SmarTrendA? Alert,
an automated pattern recognition system, indicated a DOWNTREND on
05-07-2012 for BMO @ $57.23.

As of Thursday, 02-07-2013 23:59, the latest Comtex SmarTrend Alert,
an automated pattern recognition system, indicated a DOWNTREND on
04-09-2012 for C @ $33.93.

As of Thursday, 02-07-2013 23:59, the latest Comtex SmarTrend Alert,
an automated pattern recognition system, indicated an UPTREND on
05-29-2012 for CYH @ $22.93.

For more information on SmarTrend, contact your market data
provider or go to www.mysmartrend.com

SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright A? 2004-2013 Comtex News Network, Inc. All rights reserved.

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.